首页> 外文期刊>Journal of fiber bioengineering and informatics >Preparation of Ibuprofen-loaded Poly-(Methyl Vinyl Ether-co-maleic Anhydride) Nanoparticles by Solution-enhanced Dispersion by Supercritical CO_2
【24h】

Preparation of Ibuprofen-loaded Poly-(Methyl Vinyl Ether-co-maleic Anhydride) Nanoparticles by Solution-enhanced Dispersion by Supercritical CO_2

机译:通过超临界CO_2通过溶液增强的分散制备布洛芬加载的聚 - (甲基乙烯基醚 - 二氧化马来酸酐)纳米颗粒

获取原文
获取原文并翻译 | 示例
           

摘要

Ibuprofen-loaded Poly-(methyl vinyl ether-co-maleic anhydride) (PVM/MA) nanoparticles were successfully prepared by Solution-enhanced Dispersion by Supercritical CO_2 (SEDS). Ibuprofen and PVM/MA were first homogeneously dissolved in acetone, and then the resulting solution was simultaneously sprayed with supercritical CO2 through a coaxial nozzle, forming ibuprofen-PVM/MA nanoparticles. FTIR spectra demonstrated that ibuprofen was successfully incorporated into PVM/MA and the SEDS process was a typically physical process. The absolute value of the zeta potential of the obtained ibuprofen-PVM/MA nanoparticles was larger than 40 mV, indicating a good stability of the nanoparticles in aqueous suspension and suitability for oral administration. Analysis of Thermogravimetry-differential Scanning Calorimetry (TG-DSC) revealed that the effect of the SEDS process on the thermostability of the drug and the coating polymer was negligible. The results of Gas Chromatography (GC) analysis confirmed that the SEDS process could efficiently remove the organic residue. The drug dosage of 20% corresponded to a final drug load of 5.3±0.2%, which appeared to be relatively low and indicated that most of the ibuprofen was lost in the supercritical CO2. Significant differences existed among the drug release profiles obtained from different release media; a medium with a low pH could efficiently prevent the release of ibuprofen from ibuprofen-PVM/MA nanoparticles, which works to reduce the adverse effects of ibuprofen on the stomach and makes ibuprofen-PVM/MA nanoparticles suitable for oral administration.
机译:通过超临界CO_2(SED)通过溶液增强分散来成功制备布洛芬加载的聚 - (甲基乙烯基醚 - 共马来酸酐)(PVM / MA)纳米颗粒。首先通过同轴喷嘴同时溶解在丙酮中的布洛芬和PVM / mA,然后通过同轴喷嘴将所得溶液与超临界CO2一起喷射。 FTIR光谱证明了布洛芬已成功掺入PVM / MA中,并且SEDS工艺是通常物理过程。所得布洛芬-PVM / MA纳米颗粒的Zeta电位的绝对值大于40mV,表明纳米颗粒在水性悬浮液中的良好稳定性和口服给药的适合性。热重分析扫描量热法(TG-DSC)的分析表明,SED方法对药物和涂料聚合物的热稳定性的影响可忽略不计。气相色谱(GC)分析的结果证实,SED方法可以有效地除去有机残余物。药物剂量为20%,对应于5.3±0.2%的最终药物载荷,似乎相对较低,表明大多数布洛芬在超临界CO 2中丢失。从不同释放培养基获得的药物释放型材中存在显着差异;具有低pH的培养基可以有效地防止来自布洛芬-PVM / mA纳米颗粒的布洛芬的释放,其可用于降低布洛芬对胃中的不利影响,并制备适用于口服给药的布洛芬-PVM / MA纳米颗粒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号